ArticleCancers2022
A Polytherapy Strategy Using Vincristine and ALK Inhibitors to Sensitise EML4-ALK-Positive NSCLC.
Josephina Sampson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleCancers2022
Josephina Sampson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.